NCI budget: a “Yes” to one thing means a “No” to something else, director says.
Also in this 8-page issue: Bush nominates McClellan to head CMS.
FDA to refer false statements by regulated companies to SEC.
Sandra Horning elected ASCO president-elect.
Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.
NIH appoints panel to review conflict of interest rules.
Funding opportunities listed.
PDF file includes 8-page February issue of Business & Regulatory Report.
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies